Company news
Gyre Therapeutics, Inc. news in 2021
Gyre Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 21, 2021
Catalyst Biosciences Announces Change in Corporate Strategy
November 11, 2021
Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences
October 28, 2021
Catalyst Biosciences Announces Chief Financial Officer Transition
October 12, 2021
FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency
September 27, 2021
Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
September 23, 2021
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
September 14, 2021
Catalyst Biosciences Announces Oral and Poster Presentations at the International Conference on Complement Therapeutics
September 8, 2021
Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors
September 7, 2021
Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update
August 4, 2021
Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies
July 21, 2021
Catalyst Biosciences Presents Four Posters at the International Society for Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress
July 18, 2021
Catalyst Biosciences Announces Key Leadership Changes in its Ongoing Transition to an Integrated Protease Medicines Company
July 13, 2021
Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis
July 5, 2021
Catalyst Biosciences to Host Research and Development Day on CB 4332 and Complement Programs
June 30, 2021
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Factor VII Deficiency
June 27, 2021
Catalyst Biosciences to Participate in Two Upcoming Investor Conferences
June 9, 2021
Catalyst Biosciences Announces First Patient Dosed in Marzeptacog Alfa (Activated) Phase 1/2 Study in Factor VII Deficiency, Glanzmann Thrombasthenia and Hemophilia A treated with Hemlibra
May 17, 2021
Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit
May 12, 2021
Catalyst Biosciences Reports First Quarter 2021 Operating & Financial Results and Provides a Corporate Update
May 5, 2021
Catalyst Biosciences Announces First Patient Dosed in Pivotal Phase 3 Registration Study of SQ MarzAA in Individuals with Hemophilia A or B with Inhibitors
May 4, 2021
Catalyst Biosciences Announces Publication of CB 2679d Preclinical FIX Gene Therapy Data in Blood, the Journal of the American Society of Hematology
April 18, 2021
Catalyst Biosciences Expands its Protease Medicines Patent Portfolio of Complement Factor 3 Degraders
April 11, 2021
Catalyst Biosciences to Present at the 20th Annual Needham Virtual Healthcare Conference
April 6, 2021
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
March 3, 2021
Catalyst Biosciences to Present at the 42nd Annual Raymond James Institutional Investors Conference
February 17, 2021
Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock
February 10, 2021
Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress
February 2, 2021
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
January 28, 2021
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
January 26, 2021
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
January 25, 2021
Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress
January 19, 2021
Decks in 2021
- Technical Presentation (September 2021)
Technical · 14 slides · Sep 9, 2021